An authoritative survey of the scientific background for therapeutic cancer vaccines the
challenges to their development and their current uses in treating cancer. The authors examine
the basic issues that effect all vaccines (such as immune adjuvants and prime-boost strategies)
describe the methods for antigen discovery and review the preclinical development phases for
each major vaccine strategy. They also spell out the clinical results for cancer vaccines now
beginning to be used in the treatment of many common cancers.
